195 related articles for article (PubMed ID: 34563949)
1. Depletion of β3-adrenergic receptor relieves pressure overload-induced cardiac hypertrophy and heart failure via enhancing innate immune response.
Wei X; Zhang A; Yang W; Fang Y
Biomed Pharmacother; 2021 Nov; 143():112194. PubMed ID: 34563949
[TBL] [Abstract][Full Text] [Related]
2. Depletion of β3-adrenergic receptor induces left ventricular diastolic dysfunction via potential regulation of energy metabolism and cardiac contraction.
Yang W; Wei X; Su X; Shen Y; Jin W; Fang Y
Gene; 2019 May; 697():1-10. PubMed ID: 30790654
[TBL] [Abstract][Full Text] [Related]
3. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
[TBL] [Abstract][Full Text] [Related]
4. Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice.
Velten M; Duerr GD; Pessies T; Schild J; Lohner R; Mersmann J; Dewald O; Zacharowski K; Klaschik S; Hilbert T; Hoeft A; Baumgarten G; Meyer R; Boehm O; Knuefermann P
Cardiovasc Res; 2012 Dec; 96(3):422-32. PubMed ID: 22977006
[TBL] [Abstract][Full Text] [Related]
5. The disruption of invariant natural killer T cells exacerbates cardiac hypertrophy and failure caused by pressure overload in mice.
Takahashi M; Kinugawa S; Takada S; Kakutani N; Furihata T; Sobirin MA; Fukushima A; Obata Y; Saito A; Ishimori N; Iwabuchi K; Tsutsui H
Exp Physiol; 2020 Mar; 105(3):489-501. PubMed ID: 31957919
[TBL] [Abstract][Full Text] [Related]
6. Eicosapentaenoic acid suppresses adverse effects of C-reactive protein overexpression on pressure overload-induced cardiac remodeling.
Nagai T; Anzai T; Mano Y; Kaneko H; Anzai A; Sugano Y; Maekawa Y; Takahashi T; Yoshikawa T; Fukuda K
Heart Vessels; 2013 May; 28(3):404-11. PubMed ID: 22875408
[TBL] [Abstract][Full Text] [Related]
7. Targeting E3 Ubiquitin Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination.
Zhao D; Zhong G; Li J; Pan J; Zhao Y; Song H; Sun W; Jin X; Li Y; Du R; Nie J; Liu T; Zheng J; Jia Y; Liu Z; Liu W; Yuan X; Liu Z; Song J; Kan G; Li Y; Liu C; Gao X; Xing W; Chang YZ; Li Y; Ling S
Circulation; 2021 Aug; 144(9):694-711. PubMed ID: 34139860
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.
Higashikuni Y; Tanaka K; Kato M; Nureki O; Hirata Y; Nagai R; Komuro I; Sata M
J Am Heart Assoc; 2013 Nov; 2(6):e000267. PubMed ID: 24249711
[TBL] [Abstract][Full Text] [Related]
9. Innate Immune Nod1/RIP2 Signaling Is Essential for Cardiac Hypertrophy but Requires Mitochondrial Antiviral Signaling Protein for Signal Transductions and Energy Balance.
Lin HB; Naito K; Oh Y; Farber G; Kanaan G; Valaperti A; Dawood F; Zhang L; Li GH; Smyth D; Moon M; Liu Y; Liang W; Rotstein B; Philpott DJ; Kim KH; Harper ME; Liu PP
Circulation; 2020 Dec; 142(23):2240-2258. PubMed ID: 33070627
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-4 deficiency accelerates the transition from compensated hypertrophy to heart failure following pressure overload.
Li G; Xie J; Chen J; Li R; Wu H; Zhang X; Chen Q; Gu R; Xu B
Cardiovasc Pathol; 2017; 28():74-79. PubMed ID: 28395201
[TBL] [Abstract][Full Text] [Related]
11. The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophy.
Taglieri DM; Johnson KR; Burmeister BT; Monasky MM; Spindler MJ; DeSantiago J; Banach K; Conklin BR; Carnegie GK
J Mol Cell Cardiol; 2014 Jan; 66():27-40. PubMed ID: 24161911
[TBL] [Abstract][Full Text] [Related]
12. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
[TBL] [Abstract][Full Text] [Related]
13. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED
Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152
[TBL] [Abstract][Full Text] [Related]
14. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
[TBL] [Abstract][Full Text] [Related]
15. [The Observation of Liver and Kidney Injury and the Activation of Macrophages in the Overload Pressure Induced Cardiac Hypertrophy/Heart Failure Mouse Model].
Quan Y; Tian GE; Zhou JT; Wu WC; Liu XJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):331-336. PubMed ID: 32543138
[TBL] [Abstract][Full Text] [Related]
16. Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade.
Niizeki T; Takeishi Y; Kitahara T; Arimoto T; Ishino M; Bilim O; Suzuki S; Sasaki T; Nakajima O; Walsh RA; Goto K; Kubota I
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H245-55. PubMed ID: 18487437
[TBL] [Abstract][Full Text] [Related]
17. Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure.
Zhang L; Liu M; Jiang H; Yu Y; Yu P; Tong R; Wu J; Zhang S; Yao K; Zou Y; Ge J
J Cell Mol Med; 2016 Mar; 20(3):459-70. PubMed ID: 26647902
[TBL] [Abstract][Full Text] [Related]
18. Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via β3-AR-nNOS-NO activation.
Wang B; Xu M; Li W; Li X; Zheng Q; Niu X
PLoS One; 2017; 12(6):e0179648. PubMed ID: 28622359
[TBL] [Abstract][Full Text] [Related]
19. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.
You J; Wu J; Zhang Q; Ye Y; Wang S; Huang J; Liu H; Wang X; Zhang W; Bu L; Li J; Lin L; Ge J; Zou Y
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H552-H562. PubMed ID: 29196344
[TBL] [Abstract][Full Text] [Related]
20. Ventricular TLR4 Levels Abrogate TLR2-Mediated Adverse Cardiac Remodeling upon Pressure Overload in Mice.
Kessler EL; Wang JW; Kok B; Brans MA; Nederlof A; van Stuijvenberg L; Huang C; Vink A; Arslan F; Efimov IR; Lam CSP; Vos MA; de Kleijn DPV; Fontes MSC; van Veen TAB
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
